Summary In previous studies, highly heterogeneous uptake of '3'1-labelled chimeric monoclonal antibody G250 (['3'11]cG250) in prmary renal cell carcinomas has been observed (intratumoral differences > factor 100). In this study, we investigated a possible correlation between intratumoral antibody uptake and four immunohistochemicalty determined parameters: G250 antigen expression, blood (Juweid et al. 1995 : Press et al. 1995 : Kaminski et al. 1996 more modest results hax-e been reported for solid tumours (Wilder et al. 1996. review). Marked heterogeneitx of intratumoral antibody uptake has frequently been obserned and is thought to be an important factor limiting the therapeutic efficacy of radioimmunotherapy. It has been postulated that heterogeneic antibody uptake mi,ght be explained by heterogeneity in expression of the tumour-associated antigen (Wilder et al. 1996) and/or by xascular parameters such as x ascular volume. blood flow-rate or xascular permeabilitx (Blumenthal et al. 1992) . Insight into the factors that determine antibody uptake may lead to approaches to achiex e optimal. more homogeneous antibodv uptake.
Radioimmunoscintigraphv and radioimmunotherapy w-ith radiolabelled monoclonal antibodies (MIAbs) are relativelv nexx approaches in the diagnosis and management of cancer. Although recent studies have shown that radioimmunotherapy in haematological malignancies can lead to complete and lasting responses in the majority of patients (Juweid et al. 1995 : Press et al. 1995 : Kaminski et al. 1996 more modest results hax-e been reported for solid tumours (Wilder et al. 1996. review) . Marked heterogeneitx of intratumoral antibody uptake has frequently been obserned and is thought to be an important factor limiting the therapeutic efficacy of radioimmunotherapy. It has been postulated that heterogeneic antibody uptake mi,ght be explained by heterogeneity in expression of the tumour-associated antigen (Wilder et al. 1996) and/or by xascular parameters such as x ascular volume. blood flow-rate or xascular permeabilitx (Blumenthal et al. 1992) . Insight into the factors that determine antibody uptake may lead to approaches to achiex e optimal. more homogeneous antibodv uptake.
In a phase I protein dose escalation studx-wxith "II-labelled chimeric MAb G250 (cG250) in patients with primary renal cell
Correspondence to: MG Steffens carcinoma (RCC). excellent tumour targeting >-as observed and dosimetric analy'sis indicated that therapeutic responses minght be achieved if high doses of radioactivitx w-ere administered (Steffens et al. 1997) . Howex er. marked heterogeneitv in tumour uptake was obserxed: uptake of MAb cG250 in tumour samples ranged bets een 0.0015% and 0.1651% of the injected dose per gram (%cIDg-) wxithin the same tumour. Here x-e present the results of a study investigating whether this heterogeneity could be attributed to a series of parameters that could be determined immunohistochemi- amount of MAb cG250 (5 and 10 mg). whereas the other two patients received a high amount of MAb cG250 (50 mg). As has been observed with murine G250 (Oosterwijk et al. 1993) . tumour saturation may occur at higher protein dose levels (2 25 mg). Saturation of G250 epitopes on tumour cells leads to a more homogeneous distribution but inevitably also to a lower uptake in terms of % ID g-' (Steffens et al. 1997 ). An overview of the ranges in cG250 tumour uptake in all tumours is shown in Table 1 . As illustrated by the reconstructed image of one of the tumor slices. certain hot areas with high uptake were embedded in regions with much lower uptake (Figure 1 ). In all four cases reconstructed images always closely resembled the preoperative radioimmunoscintigramns: an example is shown in Figure 2 .
Autoradiography
The autoradiograms of selected tumour samples showed a heterogeneous distribution of ['I`] Figure 3C . Certain areas within the section do not show [l`'I]cG250 uptake on the autoradiogram.
However. these 'cold areas' showed the same amount of antigen expression as adjacent areas with high uptake ( Figure 3B ).
Immunohistochemistry
Antigen G250 was expressed in all of the analysed tumour slices.
Immunohistochemical analysis revealed that all tumour samples with high uptake (> 0.% ID-g) also showed high antigen expression (> 50% (Table 4) .
DISCUSSION
The mechanism governing antibody uptake and especially factors influencing antibody uptake in solid tumours is largely unknown. However. insight into these factors is important. as heterogeneous antibody uptake may hlmit the efficacy of radioimmunotherapy of sohd tumours.
In the present study the correlation between heterogeneity in tumour uptake of MAb ['"I] (1998) 78(9), [1208] [1209] [1210] [1211] [1212] [1213] Detailed investigations in patients in which factors determining antibody uptake are studied are rare. and the few results of clinical studies are contradictory: Buist et al (1995) investigated the relation between a number of tumour characteristics and uptake of the MAbs OV-TL 3 and chimeric MOv 18 in tumour samples of patients with ovarian carcinoma. A close correlation between antibody uptake and antigen expression was shown. whereas no relation was found with tumour size. histological classification or percentage of cancer cells. Murray et al ( 1995) Based on a mathematical model it has been postulated that bindingy of the antibody to antigen might reduce the diffusion rate of the antibody. i.e. the hypothesized 'binding barrier' (Fujimori et al. 1990 ). Because of macro-and microscopic tumour heterogeneitv the influence of the factors mentioned above may vary from one location to another in the same tumour and from one time point to the next (Jain, 1990) . In an earlier clinical study with murine MAb G250 (mG250) no apparent relation was found between the intratumoral distribution of ['131ImG250, injected 8 days before surgery, and the distribution of [99-TcJhuman serum albumin (reflecting tumour perfusion), injected a few hours before surgery (Oosterwijk et al, 1993) .
Morphologically, RCCs have a well established vascular bed. which is supposedly more leaky to macromolecules than the vasculature of normal tissue. This does not imply that all ntmour regions are well perfused. Assuming that antibody uptake is facilitated by active perfusion and a concentration gradient, a wellestablished vascular bed alone is not sufficient for appropriate, homogeneous antibody targeting of tumours. Boucher et al (1996) described that increased interstitial fluid pressure was a direct result of the angiogenesis within a tumour. Thus, when enhanced interstitial fluid pressure limits antibody uptake, it seems likely that areas with abundant neovascularization would be poorly accessible to antibody. However, in the present study no correlation was found between ['311 ]cG250 uptake and CD-31 expression or PAL-E expression. Nevertheless, this study showed in all tumours that a certain amount of vascularization (a fulfilled condition) correlates significantly with [1311] cG250 uptake when other necessary conditions (e.g. certain antigen expression) are also fulfilled. Apparently enhanced interstitial fluid pressure in tumour tissue seems to play a less important role in MAb uptake than might be expected.
In conclusion, the present study indicated that high G250 antigen expression is a prerequisite, and probably the main driving force, for high cG250 antibody uptake. However, the fulfilment of other conditions, e.g. a certain amount of vascularization, also seems necessary for the establishment of high antibody uptake.
